For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Cognex Corp.’s stock clocked out at $38.69, down -1.33% from its previous closing price of $39.21. In other words, the price has decreased by -$1.33 from its previous closing price. On the day, 0.71 million shares were traded. CGNX stock price reached its highest trading level at $39.18 during the session, while it also had its lowest trading level at $38.48.
Ratios:
To gain a deeper understanding of CGNX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 74.00. For the most recent quarter (mrq), Quick Ratio is recorded 3.31 and its Current Ratio is at 4.38. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on March 19, 2024, Upgraded its rating to Buy and sets its target price to $54 from $42 previously.
On March 14, 2024, Truist started tracking the stock assigning a Buy rating and target price of $47.
On October 05, 2023, Exane BNP Paribas started tracking the stock assigning a Outperform rating and target price of $55.Exane BNP Paribas initiated its Outperform rating on October 05, 2023, with a $55 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 12 ’24 when Kuechen Joerg sold 5,331 shares for $40.93 per share. The transaction valued at 218,212 led to the insider holds 2,934 shares of the business.
Gerst Carl sold 6,782 shares of CGNX for $274,923 on Mar 06 ’24. The EVP, Vision & ID Products now owns 0 shares after completing the transaction at $40.54 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGNX now has a Market Capitalization of 6647753728 and an Enterprise Value of 6387062784. As of this moment, Cognex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 59.30, and their Forward P/E ratio for the next fiscal year is 32.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 19.96. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.94 while its Price-to-Book (P/B) ratio in mrq is 4.41. Its current Enterprise Value per Revenue stands at 7.626 whereas that against EBITDA is 44.176.
Stock Price History:
Over the past 52 weeks, CGNX has reached a high of $59.51, while it has fallen to a 52-week low of $34.28. The 50-Day Moving Average of the stock is -2.92%, while the 200-Day Moving Average is calculated to be -8.12%.
Shares Statistics:
It appears that CGNX traded 1.57M shares on average per day over the past three months and 783130 shares per day over the past ten days. A total of 171.60M shares are outstanding, with a floating share count of 171.36M. Insiders hold about 0.27% of the company’s shares, while institutions hold 95.52% stake in the company. Shares short for CGNX as of 1711584000 were 4426853 with a Short Ratio of 2.82, compared to 1709164800 on 4449845. Therefore, it implies a Short% of Shares Outstanding of 4426853 and a Short% of Float of 2.87.
Dividends & Splits
With its trailing 12-month dividend rate of 0.285, CGNX has a forward annual dividend rate of 0.29. The stock’s 5-year Average Dividend Yield is 0.45.
Earnings Estimates
The current assessment of Cognex Corp. (CGNX) involves the perspectives of Century Aluminum Company analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $38.69, with high estimates of $1.84 and low estimates of $16.11.
Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Technology.
